Barbara Bigerna

6.5k citations

35 papers · 2.5k indexed · h-index 23

Hematology top 1%
- Acute Myeloid Leukemia Research 11
Genetics top 2%
- Chronic Lymphocytic Leukemia Research 7
Pathology and Forensic Medicine top 1%
- Lymphoma Diagnosis and Treatment 13
Immunology top 5%
- Immune Cell Function and Interaction 4
- T-cell and Retrovirus Studies 3
Oncology top 5%
Physiology
- Salivary Gland Disorders and Functions 5
Molecular Biology
- Retinoids in leukemia and cellular processes 5
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 5

Co-authors: Brunangelo Falini Roberta Pacini Stefano Pileri Alessandra Pucciarini Marcello Gambacorta Leonardo Flenghi Marco Fizzotti Pier Giuseppe Pelicci
Cited by: Hematology Genetics Pathology and Forensic Medicine
Journals: Blood (9 papers)Leukemia (3 papers)British Journal of Haematology (2 papers)
Partner nations: Italy Germany United States

In The Last Decade

Barbara Bigerna

35 papers receiving 2.4k citations

Peers

Countries citing papers authored by Barbara Bigerna

Since Specialization

Citations

This map shows the geographic impact of Barbara Bigerna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Bigerna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Bigerna more than expected).

Fields of papers citing papers by Barbara Bigerna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Bigerna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Bigerna. The network helps show where Barbara Bigerna may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Barbara Bigerna, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Barbara Bigerna Line = papers co-authored together Barbara Bigerna links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Bcor loss promotes Richter transformation of chronic lymphocytic leukemia associated with Notch1 activation in mice Leukemia ·P. Winskowski,Francesco Maria Adamo,Daniele Sorcini,Filomena De Falco,Joo Sung Jung,Giovanni Martino,Barbara Bigerna,A. Young,Jin Sha,Angela Espósito,Серик Джантасов,R. Reiter,Jessica Bordini,Lydia Scarfò,Emanuela Rosati,Paolo Ghia,Brunangelo Falini,Paolo Sportoletti	2025	2
2	Artificial Intelligence-Powered Molecular Docking and Steered Molecular Dynamics for Accurate scFv Selection of Anti-CD30 Chimeric Antigen Receptors International Journal of Molecular Sciences ·A Graf,A. De Cillis,Jonathan Stretton-Downes,Anna Godzich,Joo Sung Jung,Roberta Rossi,MSc. Yoisy Pérez Olmos,Barbara Bigerna,Marco Gentili,Kazuki Sasaki,Riccardo Rossi,迪夫小田,Carla Emiliani,Sabata Martino,Marten Beeg,Marco Gobbi,Enrico Tiacci,Brunangelo Falini,Francesco Morena,Vincenzo Maria Perriello	2024	9
3	Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML Blood Advances ·Giulia Pianigiani,Jeroen Slaats,Federica Mezzasoma,Francesca Rocchio,Suresh Aluvihara,Barbara Bigerna,Paolo Sportoletti,Simona Caruso,Andrea Marra,Anderson Ae,Eleonora Petito,Giulio Spinozzi,Sharon Shacham,Yosef Landesman,Concetta Quintarelli,Paolo Gresele,Franco Locatelli,Maria Paola Martelli,Brunangelo Falini,Lorenzo Brunetti	2022	22
4	Richter's transformation in the heart The Lancet Oncology ·Andrea Marra,Francesco Maria Adamo,Stefano Baldoni,William Gorse,Michele Giansanti,Norbert Dragon,Barbara Bigerna,Daniele Sorcini,Joo Sung Jung,NadiaA Mohamed,Rina Marcela Mejía Mendoza,Vincenzo Maria Perriello,Giovanni Martino,Stefano Ascani,Brunangelo Falini,Paolo Sportoletti	2021	2
5	Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren’s syndrome minor salivary glands PLoS ONE ·Francesco Carubbi,Alessia Alunno,Paola Cipriani,Gino Coletti,Barbara Bigerna,Mirko Manetti,Paola Di Benedetto,Onelia Bistoni,Stefan Frantz,Vasiliki Liakouli,Piero Ruscitti,Elena Bartoloni,Roberto Giacomelli,Roberto Gerli	2019	8
6	CD4−CD8− T-cells in primary Sjögren's syndrome: Association with the extent of glandular involvement Journal of Autoimmunity ·Alessia Alunno,Francesco Carubbi,Onelia Bistoni,Sara Caterbi,Elena Bartoloni,Barbara Bigerna,Roberta Pacini,Daniela Beghelli,Paola Cipriani,Roberto Giacomelli,Roberto Gerli	2014	55
7	IL-17-producing double-negative T cells are expanded in the peripheral blood, infiltrate the salivary gland and are partially resistant to corticosteroid therapy in patients with Sjögren’s syndrome Reumatismo ·Alessia Alunno,Onelia Bistoni,Elena Bartoloni,Sara Caterbi,Barbara Bigerna,Alessandra Pucciarini,Alessia Tabarrini,Roberta Mannucci,Daniela Beghelli,Brunangelo Falini,Roberto Gerli	2013	14
8	IL-17-producing CD4−CD8− T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjögren's syndrome Annals of the Rheumatic Diseases ·Alessia Alunno,Onelia Bistoni,Elena Bartoloni,Sara Caterbi,Barbara Bigerna,Alessia Tabarrini,Roberta Mannucci,Brunangelo Falini,Roberto Gerli	2012	82
9	IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas Histopathology ·Brunangelo Falini,Claudio Agostinelli,Barbara Bigerna,Alessandra Pucciarini,Roberta Pacini,Alessia Tabarrini,Flavio Falcinelli,Milena Piccioli,Marco Paulli,Marcello Gambacorta,Maurilio Ponzoni,Enrico Tiacci,Stefano Ascani,Maria Paola Martelli,Riccardo Dalla Favera,Harald Stein,Stefano Pileri	2012	66
10	FRI0001 IL-17 producing-DN T cells are expanded in the blood, infiltrate salivary glands and are resistant to corticosteroids in sjÖgren's syndrome Annals of the Rheumatic Diseases ·Alessia Alunno,Onelia Bistoni,Elena Bartoloni,Sara Caterbi,Barbara Bigerna,Alessia Tabarrini,Roberta Mannucci,Daniela Beghelli,Brunangelo Falini,Roberto Gerli	2012	1
11	A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF Leukemia ·Niccolò Bolli,Rosilene de Oliveira Brito,Maria Paola Martelli,Barbara Bigerna,Alessandra Pucciarini,Roberta Rossi,Roberta Mannucci,Nicla Manes,Valentina Pettirossi,Stefano Pileri,Ildo Nicoletti,Brunangelo Falini	2008	55
12	Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice Haematologica ·Brunangelo Falini,Maria Paola Martelli,C Mecucci,Arcangelo Liso,Niccolò Bolli,Barbara Bigerna,Alessandra Pucciarini,Stefano Pileri,Giovanna Meloni,Joann R. Basabe,Susanne Schnittger	2008	36
13	Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: impact on WHO classification Blood ·Laura Pasqualucci,Arcangelo Liso,Maria Paola Martelli,Niccolò Bolli,Roberta Pacini,Alessia Tabarrini,Marco Carini,Barbara Bigerna,Alessandra Pucciarini,Roberta Mannucci,Ildo Nicoletti,Enrico Tiacci,Giovanni Battista Meloni,Giorgina Specchia,Song hyunho,Francesco Di Raimondo,S Pileri,C Mecucci,Franco Mandelli,Brunangelo Falini	2006	71
14	Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin Leukemia ·Hilmar Quentmeier,Maria Paola Martelli,Wilhelm G. Dirks,Niccolò Bolli,Arcangelo Liso,Naeimah Ahmeed Ahseen,Ildo Nicoletti,Roberta Mannucci,Alessandra Pucciarini,Barbara Bigerna,Cristina Mecucci,H G Drexler,Brunangelo Falini	2005	122
15	ALK Expression Defines a Distinct Group of T/Null Lymphomas (“ALK Lymphomas”) with a Wide Morphological Spectrum American Journal Of Pathology ·Brunangelo Falini,Barbara Bigerna,Marco Fizzotti,Karen Pulford,Tyler Paxman,Georges Delsol,Antonino Carbone,Marco Paulli,Umberto Magrini,Fabio Menestrina,Roberto Giardini,Silvana Pilotti,Alessandra Mezzelani,Marina Alexandra Manescu,Monia Billi,Alessandra Pucciarini,Roberta Pacini,Pier Giuseppe Pelicci,Leonardo Flenghi	1998	214
16	Anti‐CD30 (BER‐H2) immunotoxins containing the type‐1 ribosome‐inactivating proteins momordin and PAP‐S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30⁺ tumour cells in vitro and in SCID mice British Journal of Haematology ·Adelmo Terenzi,Andrea Bolognesi,Laura Pasqualucci,Leonardo Flenghi,J. G. Benjafield,Harald Stein,Marshall E. Kadin,Barbara Bigerna,Letizia Polito,Pier Luigi Tazzari,Maria Paola Martelli,Fiorenzo Stirpe,Brunangelo Falini	1996	40
17	Immunotoxin therapy of hematological malignancies. PubMed ·Laura Pasqualucci,Leonardo Flenghi,Adelmo Terenzi,Andrea Bolognesi,Fiorenzo Stirpe,Barbara Bigerna,Brunangelo Falini	1996	19
18	PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. PubMed ·Brunangelo Falini,Leonardo Flenghi,Stefano Pileri,Marcello Gambacorta,Barbara Bigerna,Horst Dürkop,Florian Eitelbach,J. Thiele,Roberta Pacini,Antonio Cavaliere	1993	257
19	In vivo targeting of Hodgkin's and Reed-Sternberg cells of Hodgkin's disease with monoclonal antibody Ber-H2. Immunoscintigrafic and immunohistological evidence. Brunangelo Falini,Leonardo Flenghi,L. Fedeli,E Jenkins,N. Ungrungseesopon,H. Stein,Barbara Bigerna,Giuliana Barbabietola,S. Venturi,Giovanni Pizzolo,Andréa Bartoli,S. Pileri,Elena Sabattini,Rosanna Palumbo,MF Martelli	1992	1
20	Expression of the intestinal T‐lymphocyte associated molecule HML‐1: analysis of 75 non‐Hodgkin's lymphomas and description of the first HML‐1 positive T‐lymphoblastic tumour Histopathology ·Brunangelo Falini,Leonardo Flenghi,M Fagioli,Pier Giuseppe Pelicci,H. Stein,Barbara Bigerna,Stefano Pileri,Maria Paola Martelli	1991	13

About Barbara Bigerna

Barbara Bigerna is a scholar working on Hematology, Pathology and Forensic Medicine and Genetics, having authored 35 papers that have together received 2.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (13 papers), Acute Myeloid Leukemia Research (11 papers), Chronic Lymphocytic Leukemia Research (7 papers), Salivary Gland Disorders and Functions (5 papers), Retinoids in leukemia and cellular processes (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Immune Cell Function and Interaction (4 papers) and T-cell and Retrovirus Studies (3 papers). The work is most often cited by research in Hematology (692 citations), Genetics (555 citations) and Pathology and Forensic Medicine (929 citations). Barbara Bigerna has collaborated with scholars based in Italy, Germany and United States. Frequent co-authors include Brunangelo Falini, Roberta Pacini, Stefano Pileri, Alessandra Pucciarini, Marcello Gambacorta, Leonardo Flenghi, Marco Fizzotti, Pier Giuseppe Pelicci, Maria Paola Martelli and Giorgio Cattoretti. Their work appears in journals such as Blood, Leukemia, British Journal of Haematology, Annals of the Rheumatic Diseases and Histopathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact